Advanced search
Publication Cover
Pharmaceutical Biology Volume 55, 2017 - Issue 1
Submit an article Journal homepage
1,242
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Determination of cepharanthine in rat plasma by LC–MS/MS and its application to a pharmacokinetic study

Yingbin DengDepartment of Emergency Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
,
Weijun WuDepartment of Emergency Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
,
Sunzhi YeDepartment of Emergency Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
,
Wei WangDepartment of Emergency Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
&
Zhiyi WangDepartment of Emergency Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, ChinaCorrespondence[email protected]
Pages 1775-1779 | Received 24 Feb 2017, Accepted 05 May 2017, Published online: 19 May 2017

References

  • Azuma M, Ashida Y, Tamatani T, Motegi K, Takamaru N, Ishimaru N, Hayashi Y, Sato M. 2006. Cepharanthin, a biscoclaurine alkaloid, prevents destruction of acinar tissues in murine Sjögren's syndrome. J Rheumatol. 33:912–920.
  • Biswas KK, Tancharoen S, Sarker KP, Kawahara K, Hashiguchi T, Maruyama I. 2006. Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett. 580:703–710.
  • Chea A, Hout S, Bun SS, Tabatadze N, Gasquet M, Azas N, Elias R, Balansard G. 2007. Antimalarial activity of alkaloids isolated from Stephania rotunda. J Ethnopharmacol. 112:132–137.
  • Chen Z, Huang C, Yang YL, Ding Y, Ou-Yang HQ, Zhang YY, Xu M. 2012. Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells. Acta Pharmacol Sin. 33:101–108.
  • Desgrouas C, Chapus C, Desplans J, Travaille C, Pascual A, Baghdikian B, Ollivier E, Parzy D, Taudon N. 2014. In vitro antiplasmodial activity of cepharanthine. Malar J. 13:327.
  • Furusawa S, Wu J. 2007. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases. Life Sci. 80:1073–1079.
  • Han L, Wang Y, Guo X, Zhou Y, Zhang J, Wang N, Jiang J, Ma F, Wang Q. 2014. Downregulation of MDR1 gene by cepharanthine hydrochloride is related to the activation of c-Jun/JNK in K562/ADR cells. Biomed Res Int. 2014:164391.
  • Hao G, Liang H, Li Y, Li H, Gao H, Liu G, Liu Z. 2010. Simple, sensitive and rapid HPLC–MS/MS method for the determination of cepharanthine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 878:2923–2927.
  • Harada K, Ferdous T, Itashiki Y, Takii M, Mano T, Mori Y, Ueyama Y. 2009. Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8. Int J Oncol. 35:1025–1035.
  • Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T, et al. 1995. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein. J Pharmacol Exp Ther. 275:73–78.
  • Ikeda R, Che XF, Yamaguchi T, Ushiyama M, Zheng CL, Okumura H, Takeda Y, Shibayama Y, Nakamura K, Jeung HC, et al. 2005. Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 96:372–376.
  • Ikeda R, Vermeulen LC, Lau E, Jiang Z, Sachidanandam K, Yamada K, Kolesar JM. 2011. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells. Int J Oncol. 38:513–519.
  • Kusaka J, Hagiwara S, Hasegawa A, Kudo K, Koga H, Noguchi T. 2011. Cepharanthine improves renal ischemia-reperfusion injury in rats. J Surg Res. 171:212–217.
  • Li H, Yan Z, Ning W, Xiao-Juan G, Cai-Hong Z, Jin-Hua J, Fang M, Qing-Duan W. 2011. Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo. J Biomed Biotechnol. 2011:281651.
  • Miao Q, Wang Z, Zhang Y, Miao P, Zhao Y, Ma S. 2016. In vitro potential modulation of baicalin and baicalein on P-glycoprotein activity and expression in Caco-2 cells and rat gut sacs. Pharm Biol. 54:1548–1556.
  • National Research Council. 2016. The guide for the care and use of laboratory animals. ILAR J. 57:NP.
  • Rogosnitzky M, Danks R. 2011. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacol Rep. 63:337–347.
  • Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I, et al. 2009. P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. Int J Oncol. 34:1303–1312.
  • Seubwai W, Vaeteewoottacharn K, Hiyoshi M, Suzu S, Puapairoj A, Wongkham C, Okada S, Wongkham S. 2010. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci. 101:1590–1595.
  • Wang K, Zhao J, Lang J. 2016. The effects of verapamil on the pharmacokinetics of curculigoside in rats. Pharm Biol. 54:3001–3008.
  • Yasuda K, Moro M, Akasu M, Ohnishi A. 1989. Pharmacokinetic disposition of cepharanthin following single and multiple intravenous doses in healthy subjects. Jpn J Clin Pharmacol Ther. 20:741–749.
  • Zahedi P, De Souza R, Huynh L, Piquette-Miller M, Allen C. 2011. Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer. Mol Pharm. 8:260–269.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.